Purdue University researchers have discovered a new therapeutic target for triple-negative breast cancer. (IMAGE)

Purdue University

Purdue University researchers have discovered a new therapeutic target for triple-negative breast cancer.

Caption

A Purdue University team has discovered a new therapeutic target for triple-negative breast cancer. The team identified the role of the double-stranded ribonucleic acid known as PACT, as well as proteins that play similar roles, as viable therapeutic targets. Graduate student Addison Young (left) and Kyle Cottrell, assistant professor, in Purdue’s department of biochemistry, were authors on the research, published in the journal RNA.

Credit

Purdue University/ Joshua Clark.

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.